Literature DB >> 26330909

Factors Affecting the Variation of Maximum Speech Intelligibility in Patients With Sensorineural Hearing Loss Other Than Apparent Retrocochlear Lesions.

Izumi Yahata1, Tetsuaki Kawase2, Hiromitsu Miyazaki1, Yusuke Takata1, Daisuke Yamauchi1, Kazuhiro Nomura1, Yukio Katori1.   

Abstract

OBJECTIVES: To examine the relationship between speech intelligibilities among the similar level of hearing loss and threshold elevation of the auditory brainstem response (ABR).
METHODS: The relationship between maximum speech intelligibilities among similar levels of hearing loss and relative threshold elevation of the click-evoked ABR (ABR threshold - pure tone average at 2,000 and 4,000 Hz) was retrospectively reviewed in patients with sensorineural hearing loss (SNHL) other than apparent retrocochlear lesions as auditory neuropathy, vestibular schwannoma and the other brain lesions.
RESULTS: Comparison of the speech intelligibilities in subjects with similar levels of hearing loss found that the variation in maximum speech intelligibility was significantly correlated with the threshold elevation of the ABR.
CONCLUSION: The present results appear to support the idea that variation in maximum speech intelligibility in patients with similar levels of SNHL may be related to the different degree of dysfunctions of the inner hair cells and/or cochlear nerves in addition to those of outer hair cells.

Entities:  

Keywords:  Evoked Potentials, Auditory, Brain Stem; Hearing Loss, Sensorineural; Speech Intelligibility

Year:  2015        PMID: 26330909      PMCID: PMC4553345          DOI: 10.3342/ceo.2015.8.3.189

Source DB:  PubMed          Journal:  Clin Exp Otorhinolaryngol        ISSN: 1976-8710            Impact factor:   3.372


  25 in total

1.  Auditory neuropathy/auditory dys-synchrony detected by universal newborn hearing screening.

Authors:  Raymond Y S Ngo; Henry K K Tan; A Balakrishnan; Sok Bee Lim; Derek T Lazaroo
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2006-01-18       Impact factor: 1.675

2.  Deletion of SLC19A2, the high affinity thiamine transporter, causes selective inner hair cell loss and an auditory neuropathy phenotype.

Authors:  M C Liberman; E Tartaglini; J C Fleming; E J Neufeld
Journal:  J Assoc Res Otolaryngol       Date:  2006-04-27

3.  Correlative studies on the cochlear pathology and hearing loss in guinea-pigs after intoxication with ototoxic antibiotics.

Authors:  J Ylikoski
Journal:  Acta Otolaryngol Suppl       Date:  1974

4.  Observations on relations between thresholds for pure tones and for speech.

Authors:  R Carhart
Journal:  J Speech Hear Disord       Date:  1971-11

5.  Auditory findings in 200 cases of acoustic neuromas.

Authors:  E W Johnson
Journal:  Arch Otolaryngol       Date:  1968-12

6.  Late auditory evoked potentials can occur without brain stem potentials.

Authors:  S Satya-Murti; J R Wolpaw; A T Cacace; C A Schaffer
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1983-10

Review 7.  Absence of both auditory evoked potentials and auditory percepts dependent on timing cues.

Authors:  A Starr; D McPherson; J Patterson; M Don; W Luxford; R Shannon; Y Sininger; L Tonakawa; M Waring
Journal:  Brain       Date:  1991-06       Impact factor: 13.501

8.  Temporal bone pathology of acoustic neuroma correlating with presence of electrocochleography and absence of auditory brainstem response.

Authors:  K Kaga; S Iwasaki; A Tamura; J Suzuki; H Haebara
Journal:  J Laryngol Otol       Date:  1997-10       Impact factor: 1.469

Review 9.  Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

Authors:  Jochen Schacht; Andra E Talaska; Leonard P Rybak
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

10.  Abnormal cochlear potentials from deaf patients with mutations in the otoferlin gene.

Authors:  Rosamaria Santarelli; Ignacio Del Castillo; Montserrat Rodríguez-Ballesteros; Pietro Scimemi; Elona Cama; Edoardo Arslan; Arnold Starr
Journal:  J Assoc Res Otolaryngol       Date:  2009-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.